Heiner Dreismann and Charles Woler

NovellusDx has appointed Heiner Dreismann and Charles Woler to its board of directors. Dreismann currently serves on the boards of several public and private healthcare companies. Previously, he held several senior positions with Roche Group, including president and CEO of Roche Molecular Systems and head of global business development for Roche Diagnostics. Woler previously served as CEO of Roche France, CEO of SmithKline Beecham's European pharmaceutical business, CEO of Cadus Pharmaceuticals, CEO of Neruo3d and Endotis Pharma, and recently Biomnis.